H. Yi

发表

Effect of histology on the efficacy of immune checkpoint inhibitors in advanced non-small cell lung cancer: A systematic review and meta-analysis

L. Fu, Donghui Jin, Feng Li, 2022, Frontiers in Oncology.

Regulations on e-cigarettes: China is taking action.

Jie Zhou, Yuanda Cheng, Yousheng Mao, 2023, Pulmonology.

Identification of Tumor Microenvironment-Related Prognostic lncRNAs in Lung Adenocarcinoma

Feng Li, Shuaibo Wang, Yousheng Mao, 2021, Frontiers in Oncology.

Multi-omics analysis unravels the underlying mechanisms of poor prognosis and differential therapeutic responses of solid predominant lung adenocarcinoma

Yaru Wang, L. Fu, Ting Xiao, 2023, Frontiers in Immunology.

Extracellular Matrix/Glycopeptide Hybrid Hydrogel as an Immunomodulatory Niche for Endogenous Cardiac Repair after Myocardial Infarction

Bin Wen, Guangzhi Zhao, Xiangbin Pan, 2023, Advanced science.

The origin of severe hepatitis of unknown aetiology in children: SARS-CoV-2 or adenovirus?

Bin Lu, Yousheng Mao, H. Yi, 2022, Journal of hepatology.

Pan-cancer analysis of TRPV2 identifies its potential role as a prognostic and immunologic biomarker in oesophageal cancer

Xue-fei Wang, Yousheng Mao, H. Yi, 2023, British Journal of Cancer.

Pathological response and tumor stroma immunogenic features predict long-term survival in non-small cell lung cancer after neoadjuvant chemotherapy

Renda Li, Li Liu, J. Dong, 2024, Cellular oncology.

Analysis of surgical complexity and short-term prognostic indicators in NSCLC patients: neoadjuvant targeted therapy versus neoadjuvant chemoimmunotherapy

Donghui Jin, Z. Lv, H. Yi, 2024, Therapeutic Advances in Medical Oncology.